HF
OGEN icon

HRT Financial’s Oragenics OGEN Stock Holding History

HRT Financial’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10K Buy
+18,672
New +$14.8K ﹤0.01% 3636
2025
Q1 		– Sell
-621
Closed -$6K – 3142
2024
Q4 		$6K Sell
621
-310
-33% -$3.18K ﹤0.01% 2319
2024
Q3 		$10K Buy
+931
New +$26.3K ﹤0.01% 2229
2022
Q4 		– Sell
-7
Closed -$2K – 2940
2022
Q3 		$2K Buy
+7
New +$4.09K ﹤0.01% 2649
2021
Q4 		– Sell
-10
Closed -$10K – 3810
2021
Q3 		$10K Buy
+10
New +$12.1K ﹤0.01% 3189
2020
Q4 		– Sell
-22
Closed -$23K – 2281
2020
Q3 		$23K Buy
+22
New +$35.2K ﹤0.01% 1767

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $238M AUM 22.04% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

HRT Financial's OGEN Position: Q1 2026 in Review

HRT Financial opened a new position in Oragenics (OGEN) in Q1 2026: 18,672 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #3636 among its holdings. This is a return to the name: HRT Financial previously reported a position in OGEN as recently as Q4 2024.

HRT Financial first reported a position in OGEN in Q3 2020 and has held it in 6 quarters since. The position peaked at $23K in Q3 2020. 19 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • HRT Financial held 18,672 shares of Oragenics worth $10K as of Q1 2026.
  • Oragenics was a new HRT Financial position in Q1 2026.
  • Oragenics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3636 holding.
  • HRT Financial first reported a position in Oragenics in Q3 2020 and has held it in 6 quarters since.
  • HRT Financial's Oragenics position peaked at $23K in Q3 2020.
  • 19 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.